In the context of an ex vivo organoid model, OAd5NULL-A20 CD16-EGFRscfvs and CD16scfv-EGF transduction results in NK cell-mediated death suggesting that a targeted virotherapy in conjunction with a CD16-EGFR BICA can effectively inhibit tumor cell growth. Here, EGFR is linked to neoplasm.